Kastritis, E. Et Al. 2021. Daratumumab-based treatment for immunoglobulin light-chain amyloidosis. New England Journal of Medicine , vol.385, no.1 , 46-58.

Kastritis, E., Palladini, G., Minnema, M. C., Wechalekar, A. D., Jaccard, A., Lee, H. C., ... Sanchorawala, V.(2021). Daratumumab-based treatment for immunoglobulin light-chain amyloidosis. New England Journal of Medicine , vol.385, no.1, 46-58.

Kastritis, Efstathios Et Al. "Daratumumab-based treatment for immunoglobulin light-chain amyloidosis," New England Journal of Medicine , vol.385, no.1, 46-58, 2021

Kastritis, Efstathios Et Al. "Daratumumab-based treatment for immunoglobulin light-chain amyloidosis." New England Journal of Medicine , vol.385, no.1, pp.46-58, 2021

Kastritis, E. Et Al. (2021) . "Daratumumab-based treatment for immunoglobulin light-chain amyloidosis." New England Journal of Medicine , vol.385, no.1, pp.46-58.

@article{article, author={Efstathios Kastritis Et Al. }, title={Daratumumab-based treatment for immunoglobulin light-chain amyloidosis}, journal={New England Journal of Medicine}, year=2021, pages={46-58} }